Author

James D. Kerner

Institutions: University of California, Santa Barbara, Museum of New Mexico, Epidemiology in dermatology and evaluation of therapeutics

Observed institutions: New Mexico State University, Howard Hughes Medical Institute, University of California, Santa Barbara, University of Washington, University of Washington Medical Center, Yale University, Museum of New Mexico, Epidemiology in dermatology and evaluation of therapeutics

OpenAlex ID: A5114081085

CD22 regulates thymus-independent responses and the lifespan of B cells

1996 · Kevin L. Otipoby, Kristin B. Andersson, et al. · Nature · 388

Impaired expansion of mouse B cell progenitors lacking Btk

1995 · James D. Kerner, Mark W. Appleby, et al. · Immunity · 301

Differential Signaling by Lymphocyte Antigen Receptors

1997 · Jose Alberola-Ila, Satoshi Takaki, et al. · Annual Review of Immunology · 260

Selective induction of growth factor production and growth factor receptor expression by different signals to a single t cell

1989 · José M. Rojo, James D. Kerner, et al. · European Journal of Immunology · 20

Treatment-Refractory Actinic Keratoses Successfully Treated Using Simultaneous Combination Topical 5-Fluorouracil Cream and Imiquimod Cream: A Case–Control Study

2012 · Andrew L. Ondo, Steven R. Padilla, et al. · Dermatologic Surgery · 16

Treatment of Cutaneous Squamous Cell Carcinoma In Situ With Curettage Followed by Topical Imiquimod 5% Cream

2021 · Andrew L. Ondo, James D. Kerner, et al. · Dermatologic Surgery · 5

Superficial basal cell carcinoma treated with curettage followed by topical imiquimod cream: A retrospective study

2023 · Andrew L. Ondo, James D. Kerner, et al. · JAAD International · 1

Works count: 7

Citation count: 991

H-index: 5

I10-index: 5